Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Felix Gerhard Maria Dietlein, M.D., Ph.D.

Concepts

This page shows the publications Felix Dietlein has written about Male.
Connection Strength

0.099
  1. An 89Zr-Labeled PSMA Tracer for PET/CT Imaging of Prostate Cancer Patients. J Nucl Med. 2022 Apr; 63(4):573-583.
    View in: PubMed
    Score: 0.015
  2. [18F]-JK-PSMA-7 PET/CT Under Androgen Deprivation Therapy in Advanced Prostate Cancer. Mol Imaging Biol. 2021 04; 23(2):277-286.
    View in: PubMed
    Score: 0.015
  3. Intraindividual Comparison of 18F-PSMA-1007 with Renally Excreted PSMA Ligands for PSMA PET Imaging in Patients with Relapsed Prostate Cancer. J Nucl Med. 2020 05; 61(5):729-734.
    View in: PubMed
    Score: 0.014
  4. An 18F-Labeled PSMA Ligand for PET/CT of Prostate Cancer: First-in-Humans Observational Study and Clinical Experience with 18F-JK-PSMA-7 During the First Year of Application. J Nucl Med. 2020 02; 61(2):202-209.
    View in: PubMed
    Score: 0.013
  5. PSA-Stratified Performance of 18F- and 68Ga-PSMA PET in Patients with Biochemical Recurrence of Prostate Cancer. J Nucl Med. 2017 06; 58(6):947-952.
    View in: PubMed
    Score: 0.011
  6. A functional cancer genomics screen identifies a druggable synthetic lethal interaction between MSH3 and PRKDC. Cancer Discov. 2014 May; 4(5):592-605.
    View in: PubMed
    Score: 0.009
  7. Translational Development of a Zr-89-Labeled Inhibitor of Prostate-specific Membrane Antigen for PET Imaging in Prostate Cancer. Mol Imaging Biol. 2022 02; 24(1):115-125.
    View in: PubMed
    Score: 0.004
  8. Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma. Nat Med. 2019 12; 25(12):1916-1927.
    View in: PubMed
    Score: 0.003
  9. Combined Early and Late [68Ga]PSMA-HBED-CC PET Scans Improve Lesion Detectability in Biochemical Recurrence of Prostate Cancer with Low PSA Levels. Mol Imaging Biol. 2019 06; 21(3):558-566.
    View in: PubMed
    Score: 0.003
  10. Combined VEGF and PD-L1 Blockade Displays Synergistic Treatment Effects in an Autochthonous Mouse Model of Small Cell Lung Cancer. Cancer Res. 2018 08 01; 78(15):4270-4281.
    View in: PubMed
    Score: 0.003
  11. The tumour suppressor CYLD regulates the p53 DNA damage response. Nat Commun. 2016 08 26; 7:12508.
    View in: PubMed
    Score: 0.003
  12. Intermittent high-dose treatment with erlotinib enhances therapeutic efficacy in EGFR-mutant lung cancer. Oncotarget. 2015 Nov 17; 6(36):38458-68.
    View in: PubMed
    Score: 0.003
  13. Comparison of [(18)F]DCFPyL and [ (68)Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate Cancer. Mol Imaging Biol. 2015 Aug; 17(4):575-84.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.